biologics

News

Planning appeal blocks Lilly's €400m plant in Ireland

Eli Lilly's plans for a new biopharmaceutical manufacturing facility in Ireland that will be used to produce active ingredients for its biologic medicines, including its new Alzheimer's can

Market Access

US frets over pharma supply chain security

The pandemic highlighted how fragile the global manufacturing network is, as supply of certain products was limited and regulatory inspections became difficult to carry out.

R&D

3d illustration of molecule model. Science background with molecules and atoms

Investing in biologics excellence

In little over three decades, advances in biotechnology have noticeably disrupted the development landscape of small molecule drugs.

News

Eli Lilly plans €400m Irish plant that will create 800 jobs

Eli Lilly has said it is seeking permission to build a new biopharmaceutical manufacturing facility in Ireland that will be used to produce active ingredients for its biologic medicines, in

Views & Analysis

A line of UK One Pound Coins on top of UK Banknotes (?5, ?10, ?20)

Arecor heads for London Stock Exchange with drug reformulati...

Arecor Therapeutics is planning to float on the London stock market, to raise funding and awareness for its developmental portfolio of biologic drugs, which are based on already-marketed dr

Views & Analysis